BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22755696)

  • 1. Automated measurement of uptake in cerebellum, liver, and aortic arch in full-body FDG PET/CT scans.
    Bauer C; Sun S; Sun W; Otis J; Wallace A; Smith BJ; Sunderland JJ; Graham MM; Sonka M; Buatti JM; Beichel RR
    Med Phys; 2012 Jun; 39(6):3112-23. PubMed ID: 22755696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3D deep convolutional neural network approach for the automated measurement of cerebellum tracer uptake in FDG PET-CT scans.
    Xiong X; Linhardt TJ; Liu W; Smith BJ; Sun W; Bauer C; Sunderland JJ; Graham MM; Buatti JM; Beichel RR
    Med Phys; 2020 Mar; 47(3):1058-1066. PubMed ID: 31855287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging.
    Bagci U; Foster B; Miller-Jaster K; Luna B; Dey B; Bishai WR; Jonsson CB; Jain S; Mollura DJ
    EJNMMI Res; 2013 Jul; 3(1):55. PubMed ID: 23879987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated quantification of reference levels in liver and mediastinal blood pool for the Deauville therapy response classification using FDG-PET/CT in Hodgkin and non-Hodgkin lymphomas.
    Sadik M; Lind E; Polymeri E; Enqvist O; Ulén J; Trägårdh E
    Clin Physiol Funct Imaging; 2019 Jan; 39(1):78-84. PubMed ID: 30284376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic liver detection and standardised uptake value evaluation in whole-body Positron Emission Tomography/Computed Tomography scans.
    Chauvie S; Bertone E; Bergesio F; Terulla A; Botto D; Cerello P
    Comput Methods Programs Biomed; 2018 Mar; 156():47-52. PubMed ID: 29428075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging.
    Wu A; Zheng H; Kraenzle J; Biller A; Vanover CD; Proctor M; Sherwood L; Steffen M; Ng C; Mollura DJ; Jonsson CB
    ILAR J; 2012; 53(1):E9-21. PubMed ID: 23382267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
    Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
    Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance Evaluation of a Semi-automated Method for [
    de Boer SA; Spoor DS; Slart RHJA; Mulder DJ; Reijrink M; Borra RJH; Kramer GM; Hoekstra OS; Boellaard R; Greuter MJ
    Mol Imaging Biol; 2019 Feb; 21(1):159-167. PubMed ID: 29789994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hyperglycemia on brain and liver
    Viglianti BL; Wong KK; Wimer SM; Parameswaran A; Nan B; Ky C; Townsend DM; Rubello D; Frey KA; Gross MD
    Biomed Pharmacother; 2017 Apr; 88():1038-1045. PubMed ID: 28192877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of parametric K
    Wu J; Liu H; Ye Q; Gallezot JD; Naganawa M; Miao T; Lu Y; Chen MK; Esserman DA; Kyriakides TC; Carson RE; Liu C
    Med Phys; 2021 Sep; 48(9):5219-5231. PubMed ID: 34287939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference range for intrapatient variability in blood-pool and liver SUV for 18F-FDG PET.
    Boktor RR; Walker G; Stacey R; Gledhill S; Pitman AG
    J Nucl Med; 2013 May; 54(5):677-82. PubMed ID: 23512357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.
    Williams JM; Rani SD; Li X; Arlinghaus LR; Lee TC; MacDonald LR; Partridge SC; Kang H; Whisenant JG; Abramson RG; Linden HM; Kinahan PE; Yankeelov TE
    Med Phys; 2015 Jul; 42(7):3801-13. PubMed ID: 26133582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
    Inglese E; Leva L; Matheoud R; Sacchetti G; Secco C; Gandolfo P; Brambilla M; Sambuceti G
    J Nucl Med; 2007 Oct; 48(10):1662-9. PubMed ID: 17873124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality.
    Iagaru A; Mittra E; Minamimoto R; Jamali M; Levin C; Quon A; Gold G; Herfkens R; Vasanawala S; Gambhir SS; Zaharchuk G
    Clin Nucl Med; 2015 Jan; 40(1):1-8. PubMed ID: 25489952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer.
    Heijmen L; de Geus-Oei LF; de Wilt JH; Visvikis D; Hatt M; Visser EP; Bussink J; Punt CJ; Oyen WJ; van Laarhoven HW
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1858-67. PubMed ID: 22945372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error?
    Yau YY; Chan WS; Tam YM; Vernon P; Wong S; Coel M; Chu SK
    J Nucl Med; 2005 Feb; 46(2):283-91. PubMed ID: 15695788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy.
    Jacene HA; Leboulleux S; Baba S; Chatzifotiadis D; Goudarzi B; Teytelbaum O; Horton KM; Kamel I; Macura KJ; Tsai HL; Kowalski J; Wahl RL
    J Nucl Med; 2009 Nov; 50(11):1760-9. PubMed ID: 19837757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data.
    Schulz V; Torres-Espallardo I; Renisch S; Hu Z; Ojha N; Börnert P; Perkuhn M; Niendorf T; Schäfer WM; Brockmann H; Krohn T; Buhl A; Günther RW; Mottaghy FM; Krombach GA
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):138-52. PubMed ID: 20922522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of tumour (18) F-FDG uptake: Normalise to blood glucose or scale to liver uptake?
    Keramida G; Dizdarevic S; Bush J; Peters AM
    Eur Radiol; 2015 Sep; 25(9):2701-8. PubMed ID: 25899414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.